What are the common examination signs in patients with scleroderma?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 24, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Examination Signs in Scleroderma Patients

Scleroderma patients present with characteristic skin thickening, Raynaud phenomenon in >95% of cases, and specific vascular changes on nailfold capillaroscopy that are essential for diagnosis and classification. 1

Skin Findings

  • Skin thickening is the hallmark examination finding, measured using the modified Rodnan skin score (mRSS) which assesses 17 anatomical sites on a 0-3 scale (total range 0-51). 1
  • In diffuse cutaneous disease (dcSSc), skin involvement extends proximal to elbows/knees and includes the trunk, whereas limited cutaneous disease (lcSSc) affects only distal extremities, face, and neck. 1, 2
  • Skin thickening in dcSSc typically progresses over the first 4 years and may partially regress thereafter. 1
  • The distribution pattern of skin involvement is critical for disease classification and prognostic assessment. 2

Vascular Manifestations

  • Raynaud phenomenon is present in nearly all patients (>95%) and is often the earliest clinical manifestation. 1
  • Digital ulcers occur in approximately 50% of patients and represent severe vascular compromise. 1
  • Nailfold capillaroscopy reveals characteristic microvascular changes including capillary loss, dilated loops, and hemorrhages that are pathognomonic for scleroderma spectrum disorders. 2
  • Hand involvement commonly includes calcium deposits within soft tissues, digital ischemia, and joint contractures. 3

Musculoskeletal Findings

  • Tendon friction rubs are a specific examination finding that indicates more aggressive disease and increased risk for scleroderma renal crisis. 1
  • Inflammatory arthritis is present in approximately 15% of patients. 1
  • Joint contractures develop due to skin tightening and fibrosis, particularly affecting the hands. 3
  • Myositis or myopathy affects about 15% of patients, and those with skeletal myopathy are 2.5 times more likely to have heart failure or arrhythmias. 4

Gastrointestinal Signs

  • Gastrointestinal involvement affects nearly 90% of patients, though many findings require functional testing rather than physical examination alone. 1
  • The esophagus is most commonly involved, followed by small bowel, colon, and anorectum. 1
  • Malnutrition may be evident on examination and represents the leading cause of mortality from GI involvement. 1

Pulmonary Examination

  • Bibasilar crackles may indicate interstitial lung disease, which occurs in 40-75% of patients based on lung function changes. 1
  • Signs of pulmonary hypertension (elevated JVP, loud P2, right ventricular heave) should be sought, particularly in patients with longer disease duration and low diffusing capacity. 1

Cardiac Findings

  • Arrhythmias and signs of heart failure should be actively assessed, though cardiac involvement may be clinically silent early in disease. 1
  • Pericardial effusions can manifest with muffled heart sounds or pericardial rub. 4

Important Clinical Caveats

  • The absence of Raynaud phenomenon, abnormal nailfold capillaroscopy, or scleroderma-specific autoantibodies should prompt consideration of scleroderma mimics such as scleromyxedema, scleredema, nephrogenic systemic fibrosis, or eosinophilic fasciitis. 5
  • Some patients (1.5-8%) present with "SSc sine scleroderma" lacking definite skin involvement but developing major internal organ complications. 1
  • Rapidly progressive skin thickening with weight loss, especially in elderly patients, warrants malignancy screening. 1
  • Patients with poorly vascularized tissue and deficient soft-tissue envelopes have increased susceptibility to wound healing complications. 3

References

Guideline

Systemic Sclerosis Clinical Manifestations and Diagnosis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Diagnostic Approach to Scleroderma

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Research

Scleroderma of the Hand: Evaluation and Treatment.

The Journal of the American Academy of Orthopaedic Surgeons, 2020

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.